SI1804764T1 - Priprava hitro razpadne dozirne oblike izhajajočiz trdnega praška in stopnje sušenja z zmrzovanjem - Google Patents

Priprava hitro razpadne dozirne oblike izhajajočiz trdnega praška in stopnje sušenja z zmrzovanjem

Info

Publication number
SI1804764T1
SI1804764T1 SI200530365T SI200530365T SI1804764T1 SI 1804764 T1 SI1804764 T1 SI 1804764T1 SI 200530365 T SI200530365 T SI 200530365T SI 200530365 T SI200530365 T SI 200530365T SI 1804764 T1 SI1804764 T1 SI 1804764T1
Authority
SI
Slovenia
Prior art keywords
freeze drying
solid powder
water
manufacturing
rapidly disintegrating
Prior art date
Application number
SI200530365T
Other languages
English (en)
Inventor
Kurt Heinz Bauer
Original Assignee
Pantec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1804764(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pantec Ag filed Critical Pantec Ag
Publication of SI1804764T1 publication Critical patent/SI1804764T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI200530365T 2004-10-28 2005-10-27 Priprava hitro razpadne dozirne oblike izhajajočiz trdnega praška in stopnje sušenja z zmrzovanjem SI1804764T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105381 2004-10-28
EP05803087A EP1804764B1 (en) 2004-10-28 2005-10-27 Manufacturing of a rapidly disintegrating presentation starting from a solid powder and a step of freeze drying

Publications (1)

Publication Number Publication Date
SI1804764T1 true SI1804764T1 (sl) 2008-10-31

Family

ID=34929781

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530365T SI1804764T1 (sl) 2004-10-28 2005-10-27 Priprava hitro razpadne dozirne oblike izhajajočiz trdnega praška in stopnje sušenja z zmrzovanjem

Country Status (18)

Country Link
US (1) US8802145B2 (sl)
EP (1) EP1804764B1 (sl)
JP (1) JP4980228B2 (sl)
KR (1) KR101379297B1 (sl)
CN (2) CN102631289B (sl)
AT (1) ATE398444T1 (sl)
BR (1) BRPI0517256B8 (sl)
CA (1) CA2585426C (sl)
CY (1) CY1108343T1 (sl)
DE (1) DE602005007624D1 (sl)
DK (1) DK1804764T3 (sl)
ES (1) ES2308566T3 (sl)
HK (1) HK1171364A1 (sl)
IL (1) IL182745A (sl)
PL (1) PL1804764T3 (sl)
PT (1) PT1804764E (sl)
SI (1) SI1804764T1 (sl)
WO (1) WO2006045830A1 (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
CN106666722B (zh) * 2017-03-13 2019-03-22 广州正广生物科技有限公司 一种螺旋藻片及其制备方法
CN116115554A (zh) 2018-10-15 2023-05-16 阿普雷奇亚制药有限责任公司 在包装内形成剂型的方法和系统
EP3927314B1 (en) 2019-02-22 2023-08-23 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
AU2020223894A1 (en) 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising Ibuprofen
WO2020169991A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension
SG11202108659XA (en) * 2019-02-22 2021-09-29 Catalent Uk Swindon Zydis Ltd Minimizing aeration of suspensions during in-line mixing
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
EP0084705B1 (en) * 1981-12-11 1987-01-14 JOHN WYETH & BROTHER LIMITED Process for preparing solid shaped articles
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
JPH0948726A (ja) * 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
DK0914818T3 (da) * 1996-06-14 2005-07-04 Kyowa Hakko Kogyo Kk Intraoralt hurtigt desintegrerbar tablet
US5976577A (en) * 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
DE19931708A1 (de) * 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
EP1202716A1 (en) * 1999-08-17 2002-05-08 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
EP1166655A1 (en) * 2000-06-19 2002-01-02 Société des Produits Nestlé S.A. A shelf-stable or chilled foam product and a process for its preparation
CN1290525A (zh) * 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US6509040B1 (en) * 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
CN1197556C (zh) * 2003-02-12 2005-04-20 刘智 一种防治放疗、化疗呕吐的口腔快速崩解片剂及制备方法
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof

Also Published As

Publication number Publication date
US8802145B2 (en) 2014-08-12
BRPI0517256B8 (pt) 2021-05-25
ATE398444T1 (de) 2008-07-15
CN102631289A (zh) 2012-08-15
IL182745A (en) 2010-06-30
WO2006045830A1 (en) 2006-05-04
DE602005007624D1 (de) 2008-07-31
PT1804764E (pt) 2008-09-11
BRPI0517256B1 (pt) 2018-11-21
IL182745A0 (en) 2007-07-24
BRPI0517256A (pt) 2008-10-07
KR20070069179A (ko) 2007-07-02
CA2585426A1 (en) 2006-05-04
EP1804764B1 (en) 2008-06-18
ES2308566T3 (es) 2008-12-01
DK1804764T3 (da) 2008-09-29
US20090062241A1 (en) 2009-03-05
JP4980228B2 (ja) 2012-07-18
JP2008517979A (ja) 2008-05-29
EP1804764A1 (en) 2007-07-11
CA2585426C (en) 2013-05-14
PL1804764T3 (pl) 2008-11-28
CY1108343T1 (el) 2014-02-12
KR101379297B1 (ko) 2014-04-10
HK1171364A1 (zh) 2013-03-28
CN101065105A (zh) 2007-10-31
CN102631289B (zh) 2016-05-04

Similar Documents

Publication Publication Date Title
HK1171364A1 (zh) 高孔隙度的速崩固體劑型及其包括生產粉末和凍干步驟的製備方法
DK1917339T3 (da) Film med rengøringsmidler
WO2006053227A3 (en) Il-12 modulatory compounds
WO2007046005A3 (en) A reconstituted tobacco with bonded flavorant, smoking article and methods
IL173885A (en) Ethyl – 3– [(2– {4– (hexyloxycarbonylamino – imino – methyl) –phenylamino] –methyl} –1 – methyl – H1– benzimidazole-5-carbonyl) -pyridine-2-yl-amino] -propionic acid ethyl Aster methane sulfonate in its crystalline form ii, its containing pharmaceutical preparations, and its use in the preparation of appropriate pharmaceutical preparations for prevention after deep vein thrombosis and for the prevention of stroke and its preparation
GB2465260B (en) Techniques and materials for the accelerated removal of catalyst material from diamond bodies
CL2013001016A1 (es) Metodos y sistemas para la formacion de masas porosas para filtros para fumar, que comprende introducir continuamente un material de matriz, que contiene particulas activas y de union, en una cavidad de molde, calentar el material de matriz , y cortar la longitud de masa porosa.
WO2009043844A3 (en) Orodispersible tablets
AR055561A1 (es) Comprimidos con dispersion mejorada de la sustancia farmacologica
WO2007058923A3 (en) Composition of fentanyl citrate oral solid transmucosal dosage form, dextrose monohydrate as major excipient and binding material therefor and methods of producing them
EA200701653A1 (ru) Быстрый способ влажного формирования массы для получения содержащих кальций композиций
ITTV20050068A1 (it) Procedimento ed impianto per la fabbricazione di blocchi di conglomerato in materiale lapideo o ceramico.
WO2009130604A3 (en) Solid state forms of deferasirox salts and process for the preparation thereof
UA94386C2 (ru) Способ изготовления порций мяса
PL1761567T3 (pl) Przetwarzanie manioku
WO2004102795A3 (en) Piezoelectric composites and methods for manufacturing same
CN107913500A (zh) 利用植物秸秆配制高尔夫球钉
RU2588503C2 (ru) Способ изготовления высокотемпературной теплоизоляции
EA201390125A1 (ru) Улучшенная сушка компонентов
RU2008149403A (ru) Способ изготовления арболита
RU2358864C1 (ru) Способ изготовления изделий из бетона
HUP0300358A2 (hu) Eljárás a dohányzásról való leszokást elősegítő gyógynövényes készítmények előállítására
Hardtl et al. Reducing the risk of brown discoloration of concrete products.
TH116824B (th) องค์ประกอบทางเภสัชกรรมแบบของแข็งชนิดต่างๆ และกระบวนการการต่างๆ สำหรับการผลิตองค์ประกอบดังกล่าว
Ohira et al. Performances and Economics of Next Generation Type of Water Free Mold Releasing Agent(WFR)